Clinical Trial Update: Research on the Application of 99mTc-TCR-FAPI SPECT Imaging in Rheumatoid Arthritis [NA]

View source ↗

Summary

The trial update examines the use of the radiopharmaceutical 99mTc-TCR-FAPI for SPECT imaging in rheumatoid arthritis. It aims to assess the imaging agent's uti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• 99mTc-TCR-FAPI (Technetium-99m-labeled TCR-FAPI imaging agent)

Snippet

Sponsor: Luo Yaping | Conditions: Rheumatoid Arthritis (RA) | NA | Status: RECRUITING